InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

Delayed Data
As of Jan 14
 +0.0016 / +0.31%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for InVivo Therapeutics Holdings Corp have a median target of 37.50, with a high estimate of 37.50 and a low estimate of 37.50. The median estimate represents a +7,171.67% increase from the last price of 0.52.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in InVivo Therapeutics Holdings Corp. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.45%
Growthannually 46.22%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.